041). MetS was associated with subclinical LV systolic and LV diastolic dysfunctions. In subgroup analyses of MetS patients, the presence of fQRS on ECG had a higher E/E' ratio and lower E' velocity, indicating pronounced diastolic dysfunction, as well as lower isovolumic acceleration (IVA), indicating profound subclinical LV systolic dysfunction. E/E' ratio and IVA were independent predictors of fQRS presence in patients with MetS.
Introduction
Metabolic syndrome (MetS) consists of a clustering of several metabolic and physiological risk factors, including hyperglycemia, hypertriglyceridemia, lower high-density lipoprotein cholesterol (HDL-C), hypertension, and abdominal obesity [1] . MetS is diagnosed when three or more of these metabolic abnormalities are present in the same person, according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) [2] . MetS has been shown to be associated with left ventricular (LV) systolic and diastolic dysfunctions [3] [4] [5] . The mechanism behind cardiac impairment in MetS is multifactorial, but one of the pivotal contributors is thought to be myocardial fibrosis [6, 7] .
Fragmented QRS (fQRS) includes various RSR' patterns with different morphologies of the QRS complexes with or without the Q wave on a resting 12-lead electrocardiogram (ECG). Various RSR' patterns include an additional R wave (R') or notching in the nadir of the S wave, or the presence of > 1 R' (fragmentation) in 2 contiguous leads, corresponding to a major coronary artery territory [8] . Fragmented QRS has been shown to be a marker of myocardial fibrosis or scar tissue, and has been found to be associated with increased adverse cardiac events [9, 10] . The aim of this study was to determine if fQRS is more common in MetS patients and if the presence of fQRS on ECG can detect pronounced impairment in LV systolic and diastolic functions in MetS patients.
Methods
This study was an observational case-control study.
Study population
The study was performed at the Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital in Istanbul, Turkey. Participants enrolled in the study were selected among patients admitted to the cardiology outpatient clinic from January 2012 to November 2013. The study population included 111 (mean age 47 ± 9, 49.5% male) consecutive patients with MetS and 96 (mean age 45 ± 9, 58.3% male) control subjects without MetS.
The exclusion criteria of the present study were defined as follows: angina, acute coronary syndrome, heart failure history, congenital, pericardial and valvular heart disease, atrial fibrillation or flutter, secondary hypertension, renal disease, thyroid disorders, malignancies, chronic obstructive pulmonary disease, pulmonary hypertension, atrioventricular conduction abnormality, any QRS morphology with a QRS duration 120 ms or more (bundle branch block patterns; left, right bundle branch block and intraventricular conduction delay), segmental wall motion abnormalities, LV ejection fraction (LVEF) < 55%, pregnancy, and inflammatory diseases. Written informed consent was obtained from all patients following approval of the study by the Institutional Review Board. The study was consistent with the Declaration of Helsinki.
Study protocol
Patients with MetS and control subjects without MetS were included in the study. The following demographic data were collected for all patients: age, sex, smoking status, body mass index (BMI), waist circumference, heart rate, and blood pressure. Blood samples were drawn following an overnight fasting period to measure fasting serum glucose, plasma lipids (i.e., triglyceride, HDL-C, total cholesterol, and low-density lipoprotein cholesterol [LDL-C] concentrations) and creatinine. Standard 12-lead ECGs were taken. Conventional echocardiography and tissue Doppler imaging were performed on all the subjects.
Diagnosis and definitions
The diagnosis of MetS was based on the presence of 3 or more of the risk factors for MetS established by the NCEP ATP III 2005 guidelines: systolic blood pressure (SBP) and diastolic blood pressure (DBP) ≥ 130/≥ 85 mm Hg, fasting plasma glucose ≥ 100 mg/dL, waist circumference > 102 cm for men and > 88 cm for women, fasting triglycerides > 150 mg/dL, and HDL-C < 40 mg/dL for men and < 50 mg/dL for women [2] . Diagnosis of diabetes was based on the criteria of the World Health Organization published in 2006 [11] , and arterial hypertension was based on the recommendations of the European Society of Cardiology Hypertension Guideline, published in 2007 [12] .
Electrocardiogram
Standard 12-lead surface resting ECGs (filter range, 0.5-150 Hz, 25 mm/s, 10 mm/mV) were recorded for all the patients. These ECGs were evaluated by 2 cardiologists blinded to the patient data. Fragmented QRS was defined by the presence of various RSR' patterns (QRS duration < 120 ms) with or without Q wave, which includes an additional R wave (R') or notching of the R wave or S wave, or the presence of more than one R' fragmentation without typical bundle branch block in 2 contiguous leads corresponding to a major coronary artery territory [8] . The standard 12-lead ECG was analyzed without using any magnification.
Conventional echocardiographic examination
All transthoracic echocardiographic examinations were performed with the GE Vivid S6 Vingmed System 5 (Norway, Horten), which is equipped with 2.5-4 MHz transducers. All patients were examined in the left lateral and supine positions with 2 dimensional, M-mode, pulsed, and tissue Doppler echocardiography. Single-lead ECG recordings were obtained continuously. For all measurements, the average of at least 5 cardiac cycles was used.
M-mode measurements and conventional Doppler echocardiographic examinations were performed based on the criteria of the American Society of Echocardiography and European Society of Echocardiography guidelines [13] . LV end-systolic and end-diastolic dimensions were measured in the parasternal long-axis views. LVEF was estimated by Simpson's rule. Left atrial maximum volume was measured in apical 4-chamber view at end-diastole. The mitral inflow peak velocity during early filling (E) and late filling from atrial contraction (A) were measured. The LV mass was calculated using the formula as previously described [14] . LV mass index (LVMI) was indexed for the surface area.
Tissue Doppler imaging
Doppler tissue echocardiography was performed using transducer frequencies between 3.5 and 4.0 MHz by adjusting the spectral-pulsed Doppler signal filters until a Nyquist limit of 15 to 20 cm/s was reached, and then using the minimal optimal gain. Five consecutive cycles were recorded using a frame rate greater than 150 fps. The monitor sweep speed was set at 50 to 100 mm/s to optimize the spectral display of myocardial velocities. Every effort was made to align the pulsed-wave cursor to ensure that the Doppler angle of incidence was as close to 0 as possible to the direction of the walls. In the apical 4-chamber view, the pulsed Doppler sample volume was placed at the level of the LV mitral annulus end expiration [15] .
The peak myocardial velocity during isovolumic contraction (IVV), acceleration time (AT) of peak myocardial velocity during isovolumic contraction, peak myocardial systolic velocity (Sa), peak early and late diastolic velocities (E' and A'), isovolumic contraction time (IVCT), isovolumic relaxation time (IVRT), and ejection time (ET) were measured. The E/E' ratio was calculated. The myocardial performance index (MPI) was calculated as the sum of the IVCT and the IVRT divided by the ET. The isovolumic acceleration (IVA) was defined as the ratio of IVV divided by the AT. All measurements were obtained by a single observer who was blinded to the clinical details.
Statistical analyses
Statistical analyses were performed using the SPSS software version 17.0 for Windows (SPSS Inc., Chicago, Illinois, USA). The variables were investigated using visual (histograms, probability plots) and analytical methods (KolmogorovSmirnov/Shapiro-Wilk's test) to determine the normal distribution. Descriptive analyses are presented using means and standard deviation. The categorical variables are expressed as numbers and percentages. Numerical variables were compared using a Student's t-test or the Mann-Whitney U test. Categorical data were compared with the c 2 test. Spearman correlation coefficients were used to assess the relationship between continuous variables. Stepwise logistic univariate and multivariate regression analyses were conducted to identify significant determinants of fQRS. A p value of less than 0.05 was considered significant.
Results

Analyses of the study population
Demographic, clinical, and laboratory parameters of patients and control groups are shown in Table 1 . There were no significant differences between two groups in terms of age, gender, smoking status, heart rate, serum creatinine, and total cholesterol levels. MetS patients had significantly higher SBP, DBP, waist circumference, triglycerides, BMI, LDL-C, and fasting plasma glucose level than the controls. HDL-C levels were lower in the MetS group than in the control group. Fragmented QRS was more common among MetS patients (26.1% vs. 14.6%, p = 0.041).
LV end-systolic and diastolic diameters and LVEF were similar between the two groups. LVMI, interventricular septum (IVS), posterior wall (PW), and left atrial (LA) max volume were higher in patients with MetS. In terms of diastolic function, conventional Doppler parameters E and A, tissue Doppler parameters E' and A', and E/E' ratio were significantly impaired in MetS patients. Although Sa and IVV were similar between the two groups, IVA was significantly reduced in patients with MetS. The MPI reflecting both systolic and diastolic functions was significantly higher in patients with MetS compared to the controls (Table 2 ).
Subgroup analyses of MetS patients
After finding that fQRS is more common among MetS patients, they were divided into two groups: the fQRS (+) group (29 patients) and fQRS (-) group (81 patients). Then we compared all the parameters between these groups. In fQRS www.cardiologyjournal.org (+) MetS patients, LV end-systolic and diastolic diameters, LVEF, A, Sa, and IVV parameters were similar compared to fQRS (-) patients. In fQRS (+) MetS patients, LVMI, IVS, PW and LA max volume, E, E/E', A', and MPI were higher, while E' and IVA were lower (Table 3) .
The results of the correlation analyses are shown in Table 4 . Fragmented QRS was positively MetS -metabolic syndrome; LV -left ventricular; LVEDD -left ventricular end diastolic diameter; LVESD -left ventricular end systolic diameter; E -mitral inflow peak early diastolic wave velocity; A -mitral inflow peak late diastolic wave velocity E' -flow velocity of the early diastole using tissue Doppler echocardiography; A' -flow velocity of the late diastole using tissue Doppler echocardiography; Sa -peak velocity of myocardial systolic wave; IVV -isovolumic velocity; IVA -isovolumic acceleration; MPI -myocardial performance index correlated with DBP and SBP, waist circumference, triglyceride levels, IVS, PW, LV mass index, LA max volume, E velocity, A' velocity, E/E' ratio, and MPI. HDL levels, E' velocity, and IVA were inversely correlated with fQRS. There was no correlation between fQRS and age, fasting plasma glucose levels, number of risk factors, A velocity, Sa, or BMI. In univariate analysis, to predict the presence of fQRS in MetS patients, DBP and SBP, HDL and triglyceride levels, E/E' ratio, LV mass index, LA max volume, and IVA were found to be parameters associated with fQRS (Table 5) . After adjustment for potential confounders, fQRS was associated with E/E' ratio and IVA in multivariate logistic regression analysis.
Discussion
This study demonstrated that: 1) fQRS is more common in MetS patients; 2) MetS is associated with subclinical LV systolic dysfunction and LV diastolic dysfunction; 3) in subgroup analyses of MetS patients, the presence of fQRS on ECG was associated with more prominent subclinical LV systolic and LV diastolic dysfunctions; 4) the presence of fQRS is correlated with MetS components and LV systolic and diastolic parameters; and 5) E/E' ratio and IVA were independent predictors of fQRS presence in patients with MetS.
Metabolic syndrome is an escalating publichealth problem. The prevalence of MetS in industrialized countries is about 22% of the adult population and over 40% of those aged 50 and older [16] . MetS is associated with a 5-fold increase in the risk of type 2 diabetes mellitus and 2-fold risk of developing cardiovascular disease over the next 5 to 10 years [17] . MetS is known to be associated with deterioration in LV systolic and diastolic functions [3] [4] [5] . Myocardial fibrosis is thought to be one of the contributors to this deterioration [6, 7, 18] . Myocardial fibrosis can be diagnosed histopathologically and with the help of cardiac magnetic resonance imaging and scintigraphic methods [19, 20] . These methods are not readily available and are rather expensive.
Fragmented QRS on ECG has been found a marker of myocardial scarring or fibrosis in various diseases [8, 21, 22] . It can serve as an inexpensive and readily available electrocardiographic index of myocardial fibrosis. The prevalence of fQRS was found to be 9.2% among healthy LV -left ventricular; LVEDD -left ventricular end diastolic diameter; LVESD -left ventricular end systolic diameter; IVS -interventricular septum; PW -posterior wall; LA max volume -left atrium maximum volume; E -mitral inflow peak early diastolic wave velocity; Amitral inflow peak late diastolic wave velocity E' -flow velocity of the early diastole using tissue Doppler echocardiography; A' -flow velocity of the late diastole using tissue Doppler echocardiography; Sa -peak velocity of myocardial systolic wave; IVV -isovolumic velocity; IVA -isovolumic acceleration; MPI -myocardial performance index www.cardiologyjournal.org middle-aged Finnish subjects [23] . The prevalence is increased in various diseases, including ST elevation myocardial infarction (21.9%) [7] , cardiac sarcoidosis (75%) [21] , and chronic kidney disease (60%) [22] . These data suggest that fQRS prevalence increases with myocardial involvement. We found that the prevalence of fQRS is higher in MetS compared to non-MetS controls (26.1% vs. 14.6%, p = 0.041). Our control group was chosen from the cardiology outpatient clinic, and some patients had 1 or 2 aspects of MetS. Our control group's fQRS percentage can be expected to be higher than that of the healthy population. Metabolic syndrome is known to be associated with deterioration in LV systolic and diastolic functions [3] [4] [5] . Consistent with previous studies, in our study, MetS patients had diastolic dysfunction detected by lower E velocity and E' velocity and higher A velocity, A' velocity, E/E' ratio than the non-MetS controls. LVEF and Sa were not different, but tissue Doppler parameter IVA was lower in MetS patients, indicating LV subclinical systolic dysfunction. IVA reflects the acceleration of the myocardium at the very beginning of the isovolumic contraction period. IVA remains unaffected by the changes in the preload and afterload within the physiological range [24] . It can detect even small changes in the contractile function and is well correlated with the invasive or noninvasive measures of LV dp/dt [24, 25] . This parameter has been successfully validated in clinical studies [26, 27] .
There is no data as to whether the presence of fQRS predicts pronounced LV systolic and diastolic dysfunction in MetS patients. In our study, the presence of fQRS on ECG in MetS patients was Table 5 . Logistic regression analysis of fragmented QRS for both metabolic syndrome parameters and echocardiographic parameters in metabolic syndrome patients.
Unadjusted Adjusted
Odds ratio (95% CI) P Odds ratio (95% CI) P [28] [29] [30] . Kosmala et al. [7] used surrogate serological markers of fibrotic processes and myocardial deformation parameters, and showed that subclinical LV systolic dysfunction and diastolic dysfunction is associated with a high degree of fibrosis in MetS patients. In our study, the presence of fQRS was correlated with waist circumference, SBP and DBP, and triglyceride level. In univariate logistic regression analysis, the MetS parameters SBP and DBP, HDL, and triglyceride levels were associated with the presence of fQRS. In multivariate logistic regression analysis, only LV IVA and E/E' ratio were independent determinants of the presence of fQRS on ECG. In light of these data, we think that myocardial fibrosis occurs with the contribution of particular MetS components, and causes the deterioration of LV functions. Myocardial fibrosis causing pronounced dysfunction can be predicted by the presence of fQRS on ECG.
Limitations of the study
This study has several limitations. The first one is small sample size. Secondly, we did not assess prospectively the effect of the presence of fQRS on mortality and morbidity. Thirdly, we did not show cardiac fibrosis histopathologically or with other imaging modalities. Finally, coronary artery disease was excluded based on history, electrocardiography, or echocardiography (wall motion abnormality), and we did not perform exercise stress tests or coronary angiography.
Conclusions
Fragmented QRS is more common in MetS patients than in non-MetS patients. The presence of fQRS is associated with pronounced subclinical LV systolic dysfunction and diastolic dysfunction in MetS patients.
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